Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 

Chembio, RVR Diagnostics ink two agreements
March 2014
by  |  Email the author
EDIT CONNECT

SHARING OPTIONS:

MEDFORD, N.Y.—Chembio Diagnostics Inc. has announced the signing of a pair of agreements with RVR Diagnostics SDN BHD, granting RVR exclusive distribution rights in certain countries in Southeast Asia and allowing RVR to manufacture Chembio’s DPP HIV 1/2 Assay and DPP HIV-Syphilis Assay, as well as potentially other products. The agreements include a technology transfer, license and distribution agreement and a contract manufacturing agreement. Under the first, Chembio and RVR will collaborate to enable RVR to manufacture the licensed products, for which Chembio will receive a non-refundable signature fee, and, in approximately a year, a contingent fee based on validation of transfer activity milestones. RVR will distribute the products subject to a royalty and ongoing supply of reagents. Under the second agreement, Chembio will source products from RVR’s facility for shipment to Chembio customers outside of RVR’s exclusive territory.
 
Code:

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.